ClearPoint Neuro (CLPT) News Today $15.55 +0.89 (+6.07%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ClearPoint: Fundamentals Continue To ImproveDecember 10, 2024 | seekingalpha.comConway Capital Management Inc. Takes $1.59 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Conway Capital Management Inc. bought a new stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 141,500 shares of the company's stock, valued at approximately $1,586,000. ClearPoiDecember 10, 2024 | marketbeat.com48,250 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Purchased by Pekin Hardy Strauss Inc.Pekin Hardy Strauss Inc. bought a new stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 48,250 shares of the company's stock, valued at approNovember 25, 2024 | marketbeat.comClearPoint Neuro (CLPT) Receives a Buy from Lake StreetNovember 15, 2024 | markets.businessinsider.comClearPoint Neuro announces SmartFlow Neuro Cannula FDA authorizationNovember 14, 2024 | markets.businessinsider.comQ1 Earnings Forecast for CLPT Issued By B. RileyClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) - Investment analysts at B. Riley issued their Q1 2025 earnings per share estimates for ClearPoint Neuro in a report released on Friday, November 8th. B. Riley analyst K. Bauser anticipates that the company will earn ($0.15) per share for the quaNovember 11, 2024 | marketbeat.comThe ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New ForecastsNovember 11, 2024 | finance.yahoo.comClearPoint Neuro: Near-Term Volatility Is No ConcernNovember 10, 2024 | seekingalpha.comClearPoint Neuro Achieves Record Q3 Revenue GrowthNovember 9, 2024 | markets.businessinsider.comClearPoint Neuro trading halted, volatility trading pauseNovember 9, 2024 | markets.businessinsider.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...November 8, 2024 | finance.yahoo.comClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comClearPoint Neuro (CLPT) Gets a Buy from Lake StreetNovember 4, 2024 | markets.businessinsider.comClearPoint MR Focus Alters Brain Cases: Vanguards of Health CareNovember 4, 2024 | bloomberg.comClearPoint Neuro, Inc.: ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024October 31, 2024 | finanznachrichten.deClearPoint Neuro (CLPT) to Release Earnings on ThursdayClearPoint Neuro (NASDAQ:CLPT) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=637029)October 31, 2024 | marketbeat.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 15.1% in OctoberClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 712,200 shares, a growth of 15.1% from the September 30th total of 618,500 shares. Based on an average daily volume of 199,200 shares, the days-to-cover ratio is currently 3.6 days.October 29, 2024 | marketbeat.comTaylor Frigon Capital Management LLC Has $4.20 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Taylor Frigon Capital Management LLC reduced its position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 11.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 374,797 shares of the company's stock after selling 49,738 shares during the periodOctober 24, 2024 | marketbeat.comClearPoint Neuro, Inc. (CLPT): A Bear Case TheoryOctober 18, 2024 | msn.comClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024October 17, 2024 | globenewswire.comCubist Systematic Strategies LLC Takes $419,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Cubist Systematic Strategies LLC acquired a new stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 77,750 shares of the company's stock, valueOctober 14, 2024 | marketbeat.com101,773 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Bought by Squarepoint Ops LLCSquarepoint Ops LLC bought a new position in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 101,773 shares of the company's stock, valued at approximately $549,000. SquarepOctober 9, 2024 | marketbeat.comRenaissance Technologies LLC Increases Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Renaissance Technologies LLC lifted its holdings in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 562.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 169,700 shares of the company's stock after acquiringOctober 8, 2024 | marketbeat.comCubist Systematic Strategies LLC Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Cubist Systematic Strategies LLC bought a new position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 77,750 shares of the company's stock, valued at approximately $419,000. Cubist SysOctober 5, 2024 | marketbeat.comRinkey Investments Buys Shares of 57,015 ClearPoint Neuro, Inc. (NASDAQ:CLPT)Rinkey Investments bought a new stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 57,015 shares of the company's stock, valued aSeptember 1, 2024 | marketbeat.comHain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On TuesdayAugust 28, 2024 | msn.comLake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT)August 27, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT)August 27, 2024 | markets.businessinsider.comClearPoint Neuro Announces Early Repayment of $10 Million NoteAugust 27, 2024 | markets.businessinsider.comLegato Capital Management LLC Has $857,000 Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Legato Capital Management LLC increased its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 21.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 158,968 shares of the company's stock afteAugust 27, 2024 | marketbeat.comLake Street Capital Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $15.00Lake Street Capital lifted their target price on shares of ClearPoint Neuro from $11.00 to $15.00 and gave the stock a "buy" rating in a research note on Tuesday.August 27, 2024 | marketbeat.comClearPoint Neuro, Inc. Expected to Post Q3 2024 Earnings of ($0.19) Per Share (NASDAQ:CLPT)ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) - Investment analysts at B. Riley decreased their Q3 2024 earnings per share (EPS) estimates for ClearPoint Neuro in a research report issued on Thursday, August 8th. B. Riley analyst K. Bauser now anticipates that the company will post earningsAugust 12, 2024 | marketbeat.comClearPoint Neuro: My Favorite Growth StockAugust 9, 2024 | seekingalpha.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | msn.comClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | seekingalpha.comClearPoint Neuro Reports Second Quarter 2024 ResultsAugust 7, 2024 | uk.finance.yahoo.comHere's what to expect from ClearPoint Neuro's earningsAugust 7, 2024 | markets.businessinsider.comClearPoint Neuro (CLPT) Scheduled to Post Quarterly Earnings on WednesdayClearPoint Neuro (NASDAQ:CLPT) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=609819)July 31, 2024 | marketbeat.comEquities Analysts Set Expectations for ClearPoint Neuro, Inc.'s Q2 2024 Earnings (NASDAQ:CLPT)ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) - Analysts at B. Riley issued their Q2 2024 EPS estimates for ClearPoint Neuro in a research report issued to clients and investors on Wednesday, July 24th. B. Riley analyst K. Bauser anticipates that the company will post earnings per share of (July 29, 2024 | marketbeat.comThe 3 Best Brain-Computer Interface Stocks to Buy NowJuly 27, 2024 | investorplace.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 37.5% in JulyClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) was the target of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 855,900 shares, a drop of 37.5% from the June 30th total of 1,370,000 shares. Based on an average daily trading volume, of 207,100 shares, the short-interest ratio is presently 4.1 days.July 26, 2024 | marketbeat.comClearPoint Neuro (NASDAQ:CLPT) Now Covered by B. RileyB. Riley assumed coverage on shares of ClearPoint Neuro in a research report on Thursday. They issued a "buy" rating and a $10.00 price objective for the company.July 25, 2024 | marketbeat.comClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024July 17, 2024 | globenewswire.com7 Growth Stocks That Could 5X in 5 YearsJuly 17, 2024 | investorplace.comClearPoint Neuro (NASDAQ:CLPT) Shares Up 3.5%ClearPoint Neuro (NASDAQ:CLPT) Trading 3.5% HigherJuly 9, 2024 | marketbeat.comClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical TrialJune 20, 2024 | globenewswire.comParkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement NeuronsJune 20, 2024 | prnewswire.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 5.9% in MayClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) was the target of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 1,280,000 shares, a decline of 5.9% from the April 30th total of 1,360,000 shares. Based on an average daily volume of 164,700 shares, the short-interest ratio is currently 7.8 days.June 3, 2024 | marketbeat.com Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW CLPT Media Mentions By Week CLPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLPT News Sentiment▼0.000.60▲Average Medical News Sentiment CLPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLPT Articles This Week▼02▲CLPT Articles Average Week Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RxSight News Today InMode News Today MiMedx Group News Today Establishment Labs News Today BioLife Solutions News Today Pulse Biosciences News Today Artivion News Today Embecta News Today CeriBell News Today Liquidia News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLPT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
